摘要 |
<p>The present invention relates to polypeptides which alter the expression and/or activity of one or more tumour suppressor proteins. In particular, the present invention relates to CDB3 polypeptides which increase the expression of p53 and/or the oncogenic mutants of p53 in vivo.</p> |